Antiviral activities of individual murine IFN-α subtypes in vivo: Intramuscular injection of IFN expression constructs reduces cytomegalovirus replication

Journal of Immunology

Volumn 160, Issue 6, 1998, Pages 2932-2939

  Yeow, Wen Shuz ^a   Lawson, Cassandra M ^a   Beilharz, Manfred W ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; INTERFERON RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE EXPRESSION; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; INJECTIONS, INTRAMUSCULAR; INTERFERON-ALPHA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MUROMEGALOVIRUS; TRANSFECTION; VIRUS REPLICATION;

EID: 0032520782     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Johnson, H. M., F. W. Bazer, B. E. Szente, and M. A. Jarpe. 1994. How interferons fight disease. Sci. Am. 270:40.
2. Samuel, C. E. 1991. Antiviral actions of interferon: interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183:1.
3. Kelley, K. A., and P. M. Pitha. 1985. Characterization of a mouse interferon gene locus. I. Isolation of a cluster of four α interferon genes. Nucleic Acids Res. 13:805.
4. Dandoy, F., E. De Maeyer, F. Bonhomme, J. L. Guenet, and J. De Maeyer-Guignard. 1985. Segregation of restriction fragment length polymorphism in an interspecies cross of laboratory and wild mice indicates tight linkage of the murine interferon-β gene to the murine interferon-α gene. J. Virol. 56:216.
5. Kelley, K. A., C. A. Kozak, F. Dandoy, F. Sor, D. Skup, J. D. Windass, J. DeMaeyer-Guignard, P. M. Pitha, and E. DeMaeyer. 1983. Mapping of murine interferon-α genes to chromosome 4. Gene 26:181.
6. Isaacs, A., and J. Lindenmann. 1957. Virus interference. I. The interferon. Proc. R. Soc. London B 147:258.
7. Gresser, I. 1990. Biological effect of interferons. Soc. Invest. Dermatol. 95:S66.
8. Fleischmann, C. M., and W. R. Fleischmann. Jr. 1988. Differential antiproliferative activities of IFNs α, β and γ: kinetics of establishment of their antiproliferative effects and the rapid development of resistance to IFNs α and β. J. Biol. Regul. Homeostatic Agents 2:173.
9. Moore, M. 1983. Interferon and the immune system. II. Effect of interferon on the immune system. In Interferon: From Molecular Biology to Clinical Application. Thirty-fifth Symposium of the Society for General Microbiology. D. C. Burke and A. G. Morris, eds. Cambridge University Press, Cambridge, p. 181.
10. Belardelli, F. 1995. Role of interferons and other cytokines in the regulation of the immune response. Acta Pathol Microbiol Immunol Scand 103:161.
11. Belardelli, F., and I. Gresser. 1996. The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunol. Today 17:369.
12. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415.
13. Goren, T., D. G. Fischer, and M. Rubinstein. 1986. a. Human monocytes and lymphocytes produce different mixtures of α-interferon subtypes. J. Interferon Res. 6:323.
14. Borecky, L. 1989. Interferon after 30 years. Acta Virol. 33:378.
15. Beilharz, M. W., N. Swaminathan, C. M. Lai, P. M. Pitha, and S. J. Boyer. 1991. Relative antiviral activity of in vitro-synthesized murine interferon-αa4 and -α1. J. Interferon Res. 11:9.
16. Swaminathan, N., C. M. Lai, S. J. Boyer, M. W. Beilharz, and S. P. Klinken. 1992. Biological activities of recombinant murine interferons α1 and α4: large difference in antiproliferative effect. Antiviral Res. 19:149.
17. Finter, N. B. 1991. Why are there so many subtypes of α-interferons? J. Interferon Res. (Special Issue) 11:185.
18. Iwakura, Y., M. Asano, Y. Nishimune, and Y. Kawade. 1988. Male sterility of transgenic mice carrying exogenous mouse interferon-β gene under the control of the metallothionein enhancer-promoter. EMBO J. 7:3757.
19. Hekman, A. C., J. Trapman, A. H. Mudler, J. L. M. van Gaalen, and E. C. Zwarthoff. 1988. Interferon expression in the testes of transgenic mice leads to sterility. J. Biol. Chem. 263:12151.
20. Iwakura, Y., M. Hayashi, and M. Asano. 1993. Transgenic mice carrying interferon genes. Mol. Reprod. Dev. 36:245.
21. Cases, O., I. Seif, C. Babinet, and E. De-Maeyer. 1994. Transgenic mice carrying the interferon-beta gene placed under the control of a constitutive promoter. J. Interferon Res. 14:S206.
22. Wolff, J. A., R. W. Malone, P. Williams, W. Chong, G. Ascadi, A. Jani, and P. L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247:1465.
23. Blechynden, L. M., M. A. Lawson, H. Tabaria, M. J. Garlepp, J. Sherman, N. Raben, and C. M. Lawson. 1997. Myositis induced by naked DNA immunization with the gene for histidyl-tRNA synthetase. Hum. Gene Ther. 8:1469.
24. Ascadi, G., G. Dickson, D. R. Love, A. Jani, F. S. Walsh, A. Gurusinghe, J. A. Wolff, and K. E. Davies. 1991. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 352:815.
25. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, Y. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745.
26. Davies, H. L., M. L. Michel, and R. G. Whalen. 1993. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2:1847.
27. Lawson, C. M., W.-S. Yeow, C. M. Lee, and M. W. Beilharz. 1997. In vivo expression of an interferon alpha gene by intramuscular injection of naked DNA. J. Interferon Cytokine Res. 17:255.
28. Grundy (Chalmer), J. E., J. Trapman, J. E. Allan, G. R. Shellam, and C. J. M. Melief. 1982. Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes. Infect. Immun. 37:143.
29. Grundy (Chalmer), J. E., J. S. Mackenzie, and N. F. Stanley. 1981. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect. Immun. 32:277.
30. Allan, J. E., and G. R. Shellam. 1984. Genetic control of murine cytomegalovirus infection: Virus titres in resistant and susceptible strains of mice. Arch. Virol. 81:139.
31. Lu, S., J. Arthos, D. Montefiore, Y. Yasutomi, K. Manson, F. Mustafa, E. Johnson, J. C. Santoro, J. Wissink, J. I. Mullins, J. R. Haynes, N. Letvin, M. Wyand, and H. L. Robinson. 1996. Simian immunodeficiency virus DNA vaccine trial in macaques. J. Virol. 70:3978.
32. Bartholomaeus, W. N., H. O'Donoghue, D. Foti, C. M. Lawson, G. R. Shellam, and W. D. Reed. 1988. Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies. Immunology 64:397.
33. Vitadello, M., M. V. Schiaffino, A. Picard, M. Scarpa, and S. Schiaffino. 1994. Gene transfer in regenerating muscle. Hum. Gene Ther. 5:11.
34. Sato, Y., M. Roman, H. Tighe, D. Lee, M. Corr, M.-D. Nguyen, G. J. Silverman, M. Lotz, D. A. Carson, and E. Raz. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352.
35. Gribaudo, G., S. Ravaglia, A. Caliendo, R. Cavallo, M. Garigalo, M. G. Martinotti, and S. Landolfo. 1993. Interferons inhibit onset of murine immediate-early gene transcription. Virology 197:303.
36. Stinski, M. F., D. R. Thomsen, and J. E. Rodriguez. 1982. Synthesis of human cytomegalovirus-specified RNA and protein in interferon-treated cells at early times after infection. J. Gen. Virol. 60:261.
37. Weck, P. K., S. Apperson, L. May, and N. Stebbing. 1981. Comparison of the antiviral activities of various cloned human interferon-α subtypes in mammalian cell cultures. J. Gen. Virol. 57:233.
38. Bell, D. M., N. J. Roberts, Jr., and C. B. Hall. 1983. Different antiviral spectra of human macrophage interferon activities. Nature 305:319.
39. Fish, E. N., K. Banerjee, and N. Stebbing. 1983. Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells. Biochem. Biophys. Res. Commun. 112:537.
40. Langer, J. A., J. R. Ortaldo, and S. Pestka. 1986. Binding of human alpha-interferons to natural killer cells. J. Interferon Res. 6:97.
41. Weber, H., D. Valenzuela, G. Lujber, M. Gubler, and C. Weissmann. 1987. Single amino acid change that render human IFN-α2 biologically active on mouse cells. EMBO J. 6:591.
42. Landolfo, S., G. Gribaudo, A. Angeretti, and M. Gariglio. 1995. Mechanisms of viral inhibition by interferons. Pharmacol. Ther. 65:415.
43. Lough, J., S. Keay, J. L. Sabran, and S. E. Grossberg. 1982. Inhibition of chicken myogenesis in vitro by partially purified interferon. Biochem. Biophys. Res. Commun. 109:92.
44. Multhauf, C., and J. Lough. 1986. Interferon-mediated inhibition of differentiation in a murine myoblast cell line. J. Cell. Physiol. 126:211.
45. Garrett, K. L., M. D. Grounds, M. A. L. Maley, and M. W. Beilharz. 1992. Interferon inhibits myogenesis in vitro and in vivo. Basic Appl Myol 2:291.
46. Isaacs, A., and D. C. Burke. 1958. Mode of action of interferon. Nature 182: 1073.
47. Lockart, R. Z., Jr. 1963. Production of an interferon by L cells infected with Western equine encephalomyelitis virus. J. Bacteriol. 85:556.
48. Friedman, R. M. 1966. Effect of interferon treatment on interferon production. J. Immunol. 96:872.
49. Stewart, W. E., II, L. B. Gosser, and R. Z. Lockart, Jr. 1971. Priming: a nonantiviral function of interferon. J. Virol. 7:792.
50. Goren, T., D. G. Fischer, and M. Rubinstein. 1986. b. Priming of leukocytes selectively increases the level of some interferon-α subtypes and not others. Biochim. Biophys. Acta 887:80.
51. Rosztoczy, I. 1986. Study of the in vivo priming effect of interferon in mice. J. Gen. Virol. 67:2731.
52. Fuchsberger, N., G. Karayianni-Vasconcelos, H.-L. Kauppinen, V. Hajnicka, and P. Kontsek. 1995. Priming with interferon-α1 or interferon-α2 enhances the production of both subtypes simultaneously. J. Interferon Cytokine Res. 15:637.